(Q36589035)

English

Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network

scientific article published on 25 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network (English)

1 reference

Europe PubMed Central

15 August 2017

Erb-b2 receptor tyrosine kinase 2

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

object named as

Nancy L Keating

1 reference

Europe PubMed Central

15 August 2017

Rachel A Freedman

1

object named as

Rachel A Freedman

1 reference

Europe PubMed Central

15 August 2017

2

object named as

Melissa E Hughes

1 reference

Europe PubMed Central

15 August 2017

author name string

Rebecca A Ottesen

3

1 reference

Europe PubMed Central

15 August 2017

Jane C Weeks

4

1 reference

Europe PubMed Central

15 August 2017

Yulei He

5

1 reference

Europe PubMed Central

15 August 2017

Yu-Ning Wong

6

1 reference

Europe PubMed Central

15 August 2017

Richard Theriault

7

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

25 September 2012

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

119

1 reference

Europe PubMed Central

15 August 2017

4

1 reference

Europe PubMed Central

15 August 2017

839-846

1 reference

Europe PubMed Central

15 August 2017

Socioeconomic status and survival after an invasive breast cancer diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Completion of therapy by Medicare patients with stage III colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Missed opportunities: racial disparities in adjuvant breast cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Breast cancer trends among black and white women in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Doxorubicin cardiotoxicity in African Americans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Cardiac dysfunction in the trastuzumab clinical trials experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

NCCN outcomes research database: data collection via the Internet

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Epidemiology of anthracycline cardiotoxicity in children and adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

9 September 2017

Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

30 September 2017

Outcomes assessment in the NCCN: 1998 update. National Comprehensive Cancer Network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

30 September 2017

Can comorbidity be measured by questionnaire rather than medical record review?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

30 September 2017

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565006

28 June 2018

Adjuvant trastuzumab in HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27831

21 January 2018

Trends in racial and age disparities in definitive local therapy of early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27831

21 January 2018

Parity and disparity in first course treatment of invasive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27831

21 January 2018

Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27831

21 January 2018

Race, socioeconomic status, and breast cancer treatment and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27831

21 January 2018

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27831

21 January 2018

Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27831

21 January 2018

Outcomes assessment in the NCCN

1 reference

https://pubmed.ncbi.nlm.nih.gov/23011924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Duration of adjuvant chemotherapy for colon cancer and survival among the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/23011924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23011924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/23011924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Re: Completion of therapy by Medicare patients with stage III colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23011924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23011924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/23011924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23011924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.27831

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36589035&oldid=2106022726"